MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

L Zhang, Y Liao, L Tang - Journal of Experimental & Clinical Cancer …, 2019 - Springer
Abstract MicroRNA-34 (miR-34) has been reported to be dysregulated in various human
cancers and regarded as a tumor suppressive microRNA because of its synergistic effect …

Triple negative breast cancer: A thorough review of biomarkers

JL da Silva, NCC Nunes, P Izetti… - Critical reviews in …, 2020 - Elsevier
Triple-negative breast cancer (TNBC) is defined as a type of breast cancer with lack of
expression of estrogen receptor (ER), progesterone receptor (PR) and HER2 protein. The …

MicroRNA therapeutics in cancer: current advances and challenges

S Reda El Sayed, J Cristante, L Guyon, J Denis… - Cancers, 2021 - mdpi.com
Simple Summary Cancer is a complex disease associated with deregulation of numerous
genes. In addition, redundant cellular pathways limit efficiency of monotarget drugs in …

Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion

L Huang, L Zhang, X Chen - Briefings in bioinformatics, 2022 - academic.oup.com
MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling

R Vishnubalaji, NM Alajez - Scientific Reports, 2021 - nature.com
TGFβ signaling plays crucial role during development and cancer, however the role for
TGFβ signaling in regulating the noncoding part of the human genome in triple negative …

Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery

F Vakhshiteh, S Rahmani, SN Ostad, Z Madjd… - Life Sciences, 2021 - Elsevier
Aims Exosomes hold great promise as bio-inspired delivery vehicles. Mesenchymal stem
cells (MSCs) are recognized for their potential to yield huge quantities of exosomes. We …

Cancer stem cells in TNBC

Z Hua, J White, J Zhou - Seminars in cancer biology, 2022 - Elsevier
Triple-negative breast cancer (TNBC) is a broad collection of breast cancer that tests
negative for estrogen receptors (ER), progesterone receptors (PR), and excess human …

Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy

M Ahir, P Upadhyay, A Ghosh, S Sarker… - Biomaterials …, 2020 - pubs.rsc.org
The development of new therapeutic strategies to target triple-negative breast cancer
(TNBC) is in much demand to overcome the roadblocks associated with the existing …

Unravelling the epigenetic impact: Oxidative stress and its role in male infertility-associated sperm dysfunction

G Sudhakaran, D Kesavan, K Kandaswamy… - Reproductive …, 2024 - Elsevier
Male infertility is a multifactorial condition influenced by epigenetic regulation, oxidative
stress, and mitochondrial dysfunction. Oxidative stress-induced damage leads to epigenetic …

Androgen receptor as an emerging feasible biomarker for breast cancer

CP You, MH Leung, WC Tsang, US Khoo, H Tsoi - Biomolecules, 2022 - mdpi.com
Biomarkers can be used for diagnosis, prognosis, and prediction in targeted therapy. The
estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) are …